Your browser doesn't support javascript.
loading
Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK study.
El Badri, Salma; Tahir, Bilal; Balachandran, Kirsty; Bezecny, Pavel; Britton, Fiona; Davies, Mark; Desouza, Karen; Dixon, Simon; Hills, Daniel; Moe, Maung; Pigott, Thomas; Proctor, Andrew; Shah, Yatri; Simcock, Richard; Stansfeld, Anna; Synowiec, Alicja; Theodoulou, Marianna; Verrill, Mark; Wadhawan, Anshu; Harper-Wynne, Catherine; Wilson, Caroline.
Afiliación
  • El Badri S; Weston Park Hospital, Whitham Rd, Broomhall, Sheffield, S10 2SJ, UK. Electronic address: salma.elbadri@nhs.net.
  • Tahir B; Department of Oncology and Metabolism, The University of Sheffield, Beech Hill Road, Sheffield, S10 2SF, UK.
  • Balachandran K; Charing Cross Hospital, Imperial College Healthcare NHS Trust, Fulham Palace Rd, London, W6 8RF, UK.
  • Bezecny P; Blackpool Victoria Hospital, Whinney Heys Rd, Blackpool, FY3 8NR, UK.
  • Britton F; The Christie NHS Foundation Trust, Ogelsby Cancer Research Centre, Manchester, M20 4GJ, UK.
  • Davies M; Singleton Hospital, Sketty Ln, Sketty, Swansea, SA2 8QA, UK.
  • Desouza K; Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Hucknall Rd, Nottingham, NG5 1PB, UK.
  • Dixon S; School of Health and Related Research, The University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, UK.
  • Hills D; Weston Park Hospital, Whitham Rd, Broomhall, Sheffield, S10 2SJ, UK.
  • Moe M; Singleton Hospital, Sketty Ln, Sketty, Swansea, SA2 8QA, UK.
  • Pigott T; Leeds Cancer Centre, St James's University Hospital, Beckett St, Leeds, LS9 7TF, UK.
  • Proctor A; York Teaching Hospitals NHS Trust, Wigginton Rd, York, YO31 8HE, UK.
  • Shah Y; Mount Vernon Cancer Centre, Rickmansworth Rd, Northwood, HA6 2RN, UK.
  • Simcock R; Sussex Cancer Centre, University Hospitals Sussex, Eastern Rd, Brighton, BN2 5BE, UK.
  • Stansfeld A; Freeman Hospital, Freeman Rd, High Heaton, Newcastle upon Tyne, NE7 7DN, UK.
  • Synowiec A; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Hermitage Ln, Maidstone, ME16 9QQ, UK.
  • Theodoulou M; Royal Preston Hospital, Sharoe Green Ln, Fulwood, Preston, PR2 9HT, UK.
  • Verrill M; Freeman Hospital, Freeman Rd, High Heaton, Newcastle upon Tyne, NE7 7DN, UK.
  • Wadhawan A; Velindre University NHS Trust, Velindre Rd, Whitchurch, Cardiff, CF10 2TL, UK.
  • Harper-Wynne C; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Hermitage Ln, Maidstone, ME16 9QQ, UK.
  • Wilson C; Weston Park Hospital, Whitham Rd, Broomhall, Sheffield, S10 2SJ, UK; Department of Oncology and Metabolism, The University of Sheffield, Beech Hill Road, Sheffield, S10 2SF, UK.
Breast ; 60: 199-205, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34736090

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de la Aromatasa Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de la Aromatasa Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article